• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Healthy survival after tuberculosis.

作者信息

Datta Sumona, Evans Carlton A

机构信息

Infectious Diseases & Immunity and Wellcome Trust Imperial College Centre for Global Health Research, Imperial College London, UK; IFHAD: Innovation For Health And Development, Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; IPSYD: Innovacion Por la Salud Y el Desarollo, Asociación Benéfica Prisma, Lima, Peru.

Infectious Diseases & Immunity and Wellcome Trust Imperial College Centre for Global Health Research, Imperial College London, UK; IFHAD: Innovation For Health And Development, Laboratory for Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru; IPSYD: Innovacion Por la Salud Y el Desarollo, Asociación Benéfica Prisma, Lima, Peru.

出版信息

Lancet Infect Dis. 2019 Oct;19(10):1045-1047. doi: 10.1016/S1473-3099(19)30387-1. Epub 2019 Jul 16.

DOI:10.1016/S1473-3099(19)30387-1
PMID:31324515
Abstract
摘要

相似文献

1
Healthy survival after tuberculosis.结核病后的健康生存
Lancet Infect Dis. 2019 Oct;19(10):1045-1047. doi: 10.1016/S1473-3099(19)30387-1. Epub 2019 Jul 16.
2
Is the histopathology of nonphotochromogenic mycobacterial infections distinguishable from that caused by Mycobacterium tuberculosis?非光产色分枝杆菌感染的组织病理学与结核分枝杆菌引起的组织病理学是否有区别？
Am Rev Respir Dis. 1963 Feb;87:289-91. doi: 10.1164/arrd.1963.87.2.289.
3
[Streptomycin therapy and development of streptomycin resistant mycobacterium tuberculosis].[链霉素治疗与耐链霉素结核分枝杆菌的产生]
Rozhl Tuberk. 1950;10(5-6):126-9.
4
[Experimental Mycobacterium tuberculosis infection of the guinea pig after contact with propylene glycol].[豚鼠接触丙二醇后实验性结核分枝杆菌感染]
Riv Ist Sieroter Ital. 1951 May-Jun;26(3):212-5.
5
[Experience in tuberculosis vaccination with Mycobacterium tuberculosis typus murinus-Wells vaccine].[用鼠型结核杆菌-韦尔斯疫苗进行结核疫苗接种的经验]
Z Tuberk. 1956;107(4-5):206-12.
6
[PREVALENCE OF DIFFERENT GROUPS OF MYCOBACTERIA IN A TUBERCULOSIS HOSPITAL IN MONTEVIDEO].
Hoja Tisiol. 1963 Mar;23:43-6.
7
[Sudan black BN, staining of Mycobacterium tuberculosis & lepraemurium, failure to stain Mycobacterium leprae].[苏丹黑BN对结核分枝杆菌和鼠麻风杆菌的染色，麻风杆菌不着色]
Bull Acad Natl Med. 1953;137(19-20):295-8.
8
[Intermediate metabolism of mycobacteria. I. The cytochromes of human (H37Ra), bovine (BCG), and avian (A17) strains of Mycobacterium tuberculosis and Mycobacterium phlei].
Bull Soc Chim Biol (Paris). 1952 Mar-Apr;34(3-4):279-83.
9
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment.与健康的结核分枝杆菌感染受试者相比，结核病患者中表达KLRG1的CD4 T细胞数量减少，但会随着治疗而增加。
J Infect Dis. 2019 Jun 5;220(1):174-176. doi: 10.1093/infdis/jiz056.
10
Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages.一种增强结核分枝杆菌在巨噬细胞中存活能力的结核分枝杆菌基因的鉴定。
J Bacteriol. 2000 Jan;182(2):377-84. doi: 10.1128/JB.182.2.377-384.2000.

引用本文的文献

1
Prevalence of TB-related symptoms and self-reported disability among adult TB survivors.成年结核病幸存者中与结核病相关症状及自我报告残疾的患病率。
IJTLD Open. 2024 Dec 1;1(12):540-546. doi: 10.5588/ijtldopen.24.0141. eCollection 2024 Dec.
2
Beyond the diagnosis of drug-resistant Tuberculosis in Norway: patients' experiences before, during and after treatment.挪威耐药结核病诊断之外：患者治疗前后的经历。
BMC Public Health. 2024 Jul 6;24(1):1801. doi: 10.1186/s12889-024-19342-8.
3
A scoping review of interventions to address TB associated respiratory disability.
一项关于应对结核病相关呼吸功能障碍干预措施的范围综述。
EClinicalMedicine. 2024 May 27;73:102646. doi: 10.1016/j.eclinm.2024.102646. eCollection 2024 Jul.
4
Distinct healthcare utilization profiles of high healthcare use tuberculosis survivors: A latent class analysis.高医疗利用结核病幸存者的不同医疗利用特征：潜在类别分析。
PLoS One. 2023 Sep 21;18(9):e0291997. doi: 10.1371/journal.pone.0291997. eCollection 2023.
5
Post-TB health and wellbeing.肺结核治愈后的健康与福祉。
Int J Tuberc Lung Dis. 2023 Apr 1;27(4):248-283. doi: 10.5588/ijtld.22.0514.
6
The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.成年患者社区样本中成功治疗结核病后肺动脉高压的患病率。
Pulm Circ. 2023 Jan 1;13(1):e12184. doi: 10.1002/pul2.12184. eCollection 2023 Jan.
7
Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting.高收入环境中结核病幸存者的多病共存患病率和慢性疾病模式。
Can J Public Health. 2023 Apr;114(2):264-276. doi: 10.17269/s41997-022-00711-y. Epub 2022 Dec 2.
8
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors.作为分枝杆菌生长抑制剂的嘧啶核苷类似物。
Microorganisms. 2022 Jun 27;10(7):1299. doi: 10.3390/microorganisms10071299.
9
Culturally adapted pulmonary rehabilitation for adults living with post-tuberculosis lung disease in Kyrgyzstan: protocol for a randomised controlled trial with blinded outcome measures.文化适应性肺康复治疗吉尔吉斯斯坦肺结核病后成人：一项采用盲法结局测量的随机对照试验方案。
BMJ Open. 2022 Feb 21;12(2):e048664. doi: 10.1136/bmjopen-2021-048664.
10
"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.“这不是我的身体”：耐利福平结核病患者的治疗体验和治疗后健康状况。
PLoS One. 2021 Oct 18;16(10):e0251482. doi: 10.1371/journal.pone.0251482. eCollection 2021.